HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Adam Wysokiński Selected Research

DEAE-Dextran (Pulsar)

1/2021Serum levels of neuropeptide Y in patients with chronic schizophrenia during treatment augmentation with sarcosine (results of the double-blind randomized controlled PULSAR study).
10/2018Serum levels of TNF-alpha in patients with chronic schizophrenia during treatment augmentation with sarcosine (results of the PULSAR study).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Adam Wysokiński Research Topics

Disease

29Schizophrenia (Dementia Praecox)
01/2022 - 10/2013
9Insulin Resistance
09/2019 - 10/2013
7Depressive Disorder (Melancholia)
09/2018 - 07/2014
6Body Weight (Weight, Body)
01/2016 - 09/2012
5Bipolar Disorder (Manic Depressive Psychosis)
09/2018 - 07/2014
4Dyslipidemias (Dyslipidemia)
11/2019 - 10/2013
4Obesity
11/2019 - 10/2013
4Abdominal Obesity
08/2015 - 09/2012
3Weight Gain
01/2021 - 01/2015
3Mania (Manias)
09/2018 - 07/2014
3Metabolic Syndrome (Dysmetabolic Syndrome X)
01/2016 - 09/2012
2Inflammation (Inflammations)
01/2019 - 01/2017
2Overweight
08/2015 - 10/2013
1Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome)
01/2022
1Infections
01/2021
1Catatonic Schizophrenia
01/2020
1Major Depressive Disorder (Major Depressive Disorders)
03/2019
1Cardiovascular Diseases (Cardiovascular Disease)
01/2017
1Glucose Intolerance
01/2016
1Mood Disorders (Mood Disorder)
07/2015
1Eosinophilia
02/2015
1Priapism
01/2015
1Hypertension (High Blood Pressure)
09/2012
1Hyperlipidemias (Hyperlipidemia)
09/2012
1Neuroleptic Malignant Syndrome
06/2012

Drug/Important Bio-Agent (IBA)

11Antipsychotic Agents (Antipsychotics)IBA
01/2021 - 09/2012
10Clozapine (Clozaril)FDA LinkGeneric
01/2018 - 10/2013
7Glucose (Dextrose)FDA LinkGeneric
08/2015 - 10/2013
6Sarcosine (Methylglycine)IBA
01/2021 - 12/2015
6Insulin (Novolin)FDA Link
08/2015 - 10/2013
5Uric Acid (Urate)IBA
08/2015 - 10/2013
5CholesterolIBA
08/2015 - 10/2013
5Triglycerides (Triacylglycerol)IBA
08/2015 - 12/2014
4LDL Lipoproteins (beta Lipoproteins)IBA
08/2015 - 10/2013
4HomocysteineIBA
08/2015 - 10/2013
4HDL LipoproteinsIBA
08/2015 - 10/2013
3Biomarkers (Surrogate Marker)IBA
01/2021 - 10/2019
3Neuropeptide YIBA
01/2021 - 01/2015
3Brain-Derived Neurotrophic Factor (BDNF)IBA
11/2019 - 01/2016
3LeptinIBA
09/2019 - 01/2018
3CathelicidinsIBA
02/2018 - 01/2017
3LipidsIBA
01/2017 - 07/2015
3oxidized low density lipoproteinIBA
08/2015 - 04/2015
3CalciumIBA
08/2015 - 10/2013
2Interleukin-10 (Interleukin 10)IBA
01/2022 - 10/2019
2DEAE-Dextran (Pulsar)IBA
01/2021 - 10/2018
2Interleukin-6 (Interleukin 6)IBA
10/2020 - 01/2018
2CytokinesIBA
10/2020 - 10/2019
2Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
10/2020 - 10/2018
2GhrelinIBA
09/2019 - 01/2018
2Glycine Plasma Membrane Transport ProteinsIBA
10/2018 - 01/2018
2Agouti-Related ProteinIBA
01/2018 - 04/2015
21-(2-(dodecyloxy)ethyl)pyrrolidine hydrochloride (DEP)IBA
01/2017 - 10/2016
2C-Reactive ProteinIBA
10/2016 - 07/2015
2Hypothalamic HormonesIBA
04/2015 - 01/2015
2HDL CholesterolIBA
04/2015 - 09/2012
1Chemokine CX3CL1IBA
01/2022
1InterleukinsIBA
01/2022
1Interleukin-8 (Interleukin 8)IBA
01/2022
1Serotonin ReceptorsIBA
01/2021
1Messenger RNA (mRNA)IBA
01/2021
1HMGB1 Protein (HMG1)IBA
01/2021
1Serotonin (5 Hydroxytryptamine)IBA
01/2021
1Environmental BiomarkersIBA
01/2021
1AlarminsIBA
01/2021
1Interleukin-33IBA
01/2021
1AdipokinesIBA
01/2021
1ResistinIBA
01/2021
1ApelinIBA
01/2021
1Hormones (Hormone)IBA
01/2021
1Dopamine (Intropin)FDA LinkGeneric
01/2021
1Interleukin-17 (Interleukin 17)IBA
10/2019
1PhytohemagglutininsIBA
10/2019
1MitogensIBA
10/2019
1LigandsIBA
01/2019
1Toll-Like Receptors (Toll-Like Receptor)IBA
01/2019
1N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA
10/2018
1Glycine (Aminoacetic Acid)FDA LinkGeneric
10/2018
1Hemoglobins (Hemoglobin)IBA
09/2018
1Cocaine (Cocaine HCl)IBA
01/2018
1Peptide YYIBA
01/2018
1Amphetamine (Amfetamine)FDA LinkGeneric
01/2018
1Biological ProductsIBA
01/2018
1Nerve Growth Factors (Neurotrophins)IBA
01/2016
1LDL CholesterolIBA
07/2015
1Peptides (Polypeptides)IBA
04/2015
1LithiumIBA
01/2015
1Quetiapine Fumarate (Seroquel)FDA Link
01/2015
1cocaine- and amphetamine-regulated transcript proteinIBA
12/2014
1des-n-octanoyl ghrelinIBA
12/2014
1Blood Glucose (Blood Sugar)IBA
10/2014
1Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
07/2014
1Hypolipidemic Agents (Antihyperlipidemics)IBA
09/2012
1Pharmaceutical PreparationsIBA
06/2012

Therapy/Procedure

5Duration of Therapy
04/2015 - 10/2013
2Transcranial Direct Current Stimulation
01/2022 - 01/2020
1Cognitive Training
01/2022
1Therapeutics
09/2012